advertisement
Abstract #94380 Published in IGR 22-2
Decorin-An Antagonist of TGF-β in Astrocytes of the Optic Nerve
Schneider M; Dillinger AE; Ohlmann A; Iozzo RV; Fuchshofer RInternational journal of molecular sciences 2021; 22:
During the pathogenesis of glaucoma, optic nerve (ON) axons become continuously damaged at the optic nerve head (ONH). This often is associated with reactive astrocytes and increased transforming growth factor (TGF-β) 2 levels. In this study we tested the hypothesis if the presence or absence of decorin (DCN), a small leucine-rich proteoglycan and a natural inhibitor of several members of the TGF family, would affect the expression of the TGF-βs and connective tissue growth factor (CTGF/CCN2) in human ONH astrocytes and murine ON astrocytes. We found that DCN is present in the mouse ON and is expressed by human ONH and murine ON astrocytes. DCN expression and synthesis was significantly reduced after 24 h treatment with 3 nM CTGF/CCN2, while treatment with 4 pM TGF-β2 only reduced expression of significantly. Conversely, DCN treatment significantly reduced the expression of , and vis-a-vis untreated controls. Furthermore, DCN treatment significantly reduced expression of fibronectin () and collagen IV (). Notably, combined treatment with DCN and triciribine, a small molecule inhibitor of protein kinase B (AKT), attenuated effects of DCN on , , and mRNA expression. We conclude (1) that DCN is an important regulator of and expression in astrocytes of the ON and ONH, (2) that DCN thereby regulates the expression of extracellular matrix (ECM) components and (3) that DCN executes its negative regulatory effects on and via the pAKT/AKT signaling pathway in ON astrocytes.
Institute of Human Anatomy and Embryology, University of Regensburg, 93053 Regensburg, Germany.
Full articleClassification:
3.8 Pharmacology (Part of: 3 Laboratory methods)
3.6 Cellular biology (Part of: 3 Laboratory methods)
2.14 Optic disc (Part of: 2 Anatomical structures in glaucoma)